Latest News Archive
Please select Category, Year, and then Month to display items
11 February 2022
|
Story Leonie Bolleurs and Rulanzen Martin
![]()
After two years of lockdown, online meetings, and limited contact with colleagues, academy at the University of the Free State (UFS) is gradually returning to normal. This month (February 2022), staff, students, and members of related industries will convene on three different occasions to learn about cutting-edge scholarship, to reconnect with each other, and to discuss issues impacting society in the fields of theology, the humanities, and agriculture.
Seminar on ‘The Limits of Decolonisation’ with Prof RW Johnson
Date: 24 February 2022
Time: 09:00-16:00 SAST
Venue/Platform: Equitas Auditorium, UFS Bloemfontein Campus, and Microsoft Teams
Decolonisation has been a heated point of discussion for some time now, but have you ever wondered if there could be limitations hindering the decolonisation project? The Departments of Political Studies and Governance and Philosophy and Classics at the UFS will host an array of academics and experts for a hybrid seminar on the topic The Limits of Decolonisation.
If decolonisation is an important issue for you or if you are interested in the topic and its relevance and influence in the world and academia, you should join or attend the seminar – either online via Microsoft Teams or in person in the Equitas Auditorium – on 24 February 2022 from 09:00.
The keynote speaker is political scientist
Prof RW Johnson from the University of Oxford. Prof Johnson is an emeritus fellow at Magdalen College and is the author of several acclaimed political books. The other speakers are all from the Departments of Political Studies and Governance, and Philosophy and Classics. Terrence Corrigan from the
South African Institute of Race Relations will speak on The relationship between critical race theory and decolonisation.
RSVP: Alice Stander StanderAFM@ufs.ac.za (please specify dietary requirements, as a light lunch will be served)
DNA sequencer launched at the UFS
2013-11-25
 |
| Dr Gansen Pillay, Deputy Chief Executive Officer of the National Research Foundation, explaining to the scholars what will be expected of them. |
The University of the Free State (UFS) can now collect immensely valuable data on drug resistance in HIV/Aids and TB with the new DNA sequencer that was launched recently at the International workshop on HIV/AIDS and TB drug resistance at the Bloemfontein Campus.
The DNA sequencer will allow the Free State province to produce viral and bacterial genetic data to fight the local development of HIV/ Aids and TB drug resistance.
The HIV and TB epidemics have expanded very fast and South Africa now has the largest HIV and TB treatment programme in the world, with over 2 million patients on treatment. However, these successful treatment programmes are now being threatened by the appearance of drug resistance.
The Free State province has been at the forefront of fighting HIV drug resistance in South Africa and has one of the most advanced treatment programmes for the management of resistance strains in the country. In addition, researchers at the University of the Free State are leading partners in the Southern African Treatment and Resistance Network (SATuRN; www.bioafrica.net/saturn), a research network that has trained over 2 000 medical officers in the treatment of drug resistance strains.
The Department of Medical Microbiology and Virology in the Medical School at the UFS has partnered with the provincial department of health, the Medical Research Council (MRC) and the Delegation of the European Union to South Africa to fund a dedicated DNA sequencer machine that will be used to generate HIV and TB drug-resistance results. This new machine will enable cutting-edge research to take place, using the data in the province and, importantly, support patients with resistance strains to have access to advanced genotypic testing techniques.
“HIV drug resistance is a very serious problem in South Africa, and the recent advances in DNA testing technology allow clinicians in the province to access drug resistance testing, which enables them to manage patients appropriately who fail treatment, and use the results to cost-effectively extend and improve patients’ lives,” says Dr Cloete van Vuuren, Specialist in Infectious Diseases at the UFS’s Faculty of Health.
Dr Dominique Goedhals, pathologist from the Department of Medical Microbiology and Virology at the UFS, adds: “We have been looking forward to expanding our work with the clinicians and researchers, using DNA sequencing to shed light on the causes and consequences of drug resistance in urban and rural settings in the province.”